Impact of a “Chart Closure” Hard Stop Alert on Prescribing for Elevated Blood Pressures Among Patients With Diabetes: Quasi-Experimental Study

BACKGROUND: University of California at Los Angeles Health implemented a Best Practice Advisory (BPA) alert for the initiation of an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-receptor blocker (ARB) for individuals with diabetes. The BPA alert was configured with a “chart closure”...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez, Magaly, Chen, Kimberly, Follett, Robert W, Mangione, Carol M, Moreno, Gerardo, Bell, Douglas S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195665/
https://www.ncbi.nlm.nih.gov/pubmed/32301741
http://dx.doi.org/10.2196/16421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195665/
https://www.ncbi.nlm.nih.gov/pubmed/32301741
http://dx.doi.org/10.2196/16421

Ejemplares similares